Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Global Healthcare Conference
February 09, 2017 06:30 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside...
Sucampo Announces Pricing of $260.0 Million 3.25% Convertible Senior Notes due 2021
December 21, 2016 02:00 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), a global biopharmaceutical company, today announced the December 20, 2016 pricing of $260.0 million...
Sucampo Announces Proposed Convertible Senior Note Offering
December 19, 2016 16:01 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), a global biopharmaceutical company, today announced its intention to offer, subject to market and other...
Sucampo Names Peter Greenleaf Chief Executive Officer
February 10, 2014 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo") today announced that Peter Greenleaf will join Sucampo as Chief Executive Officer ("CEO") and...